5.9978
price down icon0.37%   -0.0222
 
loading

Finanzdaten der Tenax Therapeutics Inc-Aktie (TENX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
100.00%
-
-24.40 9.2378 7.344 -
Operating Expenses
55.43%
11.34
7.2948 4.6189 3.672 3.9083
Operating Income/Loss
64.23%
-11.34
-31.69 4.6189 3.672 -3.9083
Income/Loss From Continuing Operations Before Tax
66.08%
-10.41
-6.267 3.9605 -3.5757 -3.7988
Income/Loss From Continuing Operations After Tax
66.08%
-10.41
-6.267 3.9605 -3.5757 -3.7988
Net Income/Loss
66.08%
-10.41
-6.267 3.9605 -3.5757 -3.7988
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
100.00%
-
22.67 - - -
Basic Average Shares
36.58
- - - -
Diluted Average Shares
36.58
- - - -
Basic Earnings Per Share
-0.28
- - - -
Diluted Earnings Per Share
-0.28
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$85.64
price down icon 1.37%
$23.21
price down icon 1.15%
$27.18
price up icon 0.33%
$100.17
price down icon 0.26%
$141.75
price down icon 1.14%
biotechnology ONC
$322.15
price down icon 4.18%
Kapitalisierung:     |  Volumen (24h):